BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Romero-Ibarguengoitia ME, Rivera-Salinas D, Hernández-Ruíz YG, Armendariz-Vázquez AG, González-Cantú A, Barco-Flores IA, González-Facio R, Montelongo-Cruz LP, Del Rio-Parra GF, Garza-Herrera MR, Leal-Meléndez JA, Sanz-Sánchez MÁ. Effect of the third dose of BNT162b2 vaccine on quantitative SARS-CoV-2 spike 1-2 IgG antibody titers in healthcare personnel. PLoS One 2022;17:e0263942. [PMID: 35235587 DOI: 10.1371/journal.pone.0263942] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Tanaka H, Mukai J, Kushibiki K, Mizushima S, Maeda K, Fujimoto Y, Sawada R, Oda M, Okuda H, Yamaki M, Hashiguchi S, Kawai I, Kawaguchi I, Masuda N, Matsushita H. Effect of the third dose of BNT162b2 COVID-19 mRNA vaccine on anti-SARS-CoV-2 antibody levels in healthcare workers. Vaccine 2022. [DOI: 10.1016/j.vaccine.2022.11.049] [Reference Citation Analysis]
2 Ailsworth SM, Keshavarz B, Richards NE, Workman LJ, Murphy DD, Nelson MR, Platts-Mills TAE, Wilson JM. Enhanced SARS-CoV-2 IgG durability following COVID-19 mRNA booster vaccination and comparison of BNT162b2 with mRNA-1273. Ann Allergy Asthma Immunol 2022:S1081-1206(22)01829-4. [PMID: 36241020 DOI: 10.1016/j.anai.2022.10.003] [Reference Citation Analysis]
3 Parisi SG, Mengoli C, Basso M, Vicenti I, Gatti F, Scaggiante R, Fiaschi L, Giammarino F, Iannetta M, Malagnino V, Zago D, Dragoni F, Zazzi M. Long-Term Longitudinal Analysis of Neutralizing Antibody Response to Three Vaccine Doses in a Real-Life Setting of Previously SARS-CoV-2 Infected Healthcare Workers: A Model for Predicting Response to Further Vaccine Doses. Vaccines 2022;10:1237. [DOI: 10.3390/vaccines10081237] [Reference Citation Analysis]
4 Tani N, Ikematsu H, Goto T, Gondo K, Inoue T, Yanagihara Y, Kurata Y, Oishi R, Minami J, Onozawa K, Nagano S, Kuwano H, Akashi K, Shimono N, Chong Y. Correlation of post-vaccination fever with specific antibody response to SARS-CoV-2 BNT162b2 booster and no significant influence of antipyretic medication.. [DOI: 10.1101/2022.07.25.22277569] [Reference Citation Analysis]
5 Lee N, Jeong S, Lee SK, Cho E, Hyun J, Park M, Song W, Kim HS. Quantitative Analysis of Anti-N and Anti-S Antibody Titers of SARS-CoV-2 Infection after the Third Dose of COVID-19 Vaccination. Vaccines 2022;10:1143. [DOI: 10.3390/vaccines10071143] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
6 Ekström N, Haveri A, Solastie A, Virta C, Österlund P, Nohynek H, Nieminen T, Ivaska L, Tähtinen PA, Lempainen J, Jalkanen P, Julkunen I, Palmu AA, Melin M. Strong neutralizing antibody responses to SARS-CoV-2 variants following a single vaccine dose in subjects with previous SARS-CoV-2 infection.. [DOI: 10.1101/2022.07.04.22277223] [Reference Citation Analysis]
7 Takeuchi M, Esaki A, Higa Y, Nakazono A. Temporal changes in spike IgG levels after two doses of BNT162b2 vaccine in Japanese healthcare workers: Do spike IgG levels at 3 months predict levels 6 or 8 months after vaccination? PLoS ONE 2022;17:e0263486. [DOI: 10.1371/journal.pone.0263486] [Reference Citation Analysis]
8 Cheng H, Peng Z, Si S, Alifu X, Zhou H, Chi P, Zhuang Y, Mo M, Yu Y. Immunogenicity and Safety of Homologous and Heterologous Prime–Boost Immunization with COVID-19 Vaccine: Systematic Review and Meta-Analysis. Vaccines 2022;10:798. [DOI: 10.3390/vaccines10050798] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
9 Padoan A, Cosma C, Della Rocca F, Barbaro F, Santarossa C, Dall'Olmo L, Galla L, Cattelan A, Cianci V, Basso D, Plebani M. A cohort analysis of SARS-CoV-2 anti-spike protein receptor binding domain (RBD) IgG levels and neutralizing antibodies in fully vaccinated healthcare workers. Clin Chem Lab Med 2022. [PMID: 35473824 DOI: 10.1515/cclm-2022-0322] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Sanna G, Marongiu A, Firinu D, Piras C, Franci G, Galdiero M, Pala G, Palmas V, Angius F, Littera R, Perra A, Orrù G, Campagna M, Costanzo G, Meloni F, Coghe F, Chessa L, Manzin A. Neutralizing Antibodies Responses against SARS-CoV-2 in a Sardinian Cohort Group Up to 9 Months after BNT162b2 Vaccination. Vaccines 2022;10:531. [DOI: 10.3390/vaccines10040531] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]